Cerus (CERS) Share-based Compensation Growth (3y) (2013 - 2026)
Cerus (CERS) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | - |
| 10 | Cerus | 604.75 Mn | 524.33 Mn | 27.89 Mn | -4.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.72% |
| Dec 31, 2025 | -12.10% |
| Sep 30, 2025 | -0.84% |
| Jun 30, 2025 | 4.30% |
| Mar 31, 2025 | 1.07% |
| Dec 31, 2024 | -5.58% |
| Sep 30, 2024 | -0.35% |
| Jun 30, 2024 | -0.75% |
| Mar 31, 2024 | 3.16% |
| Dec 31, 2023 | 1.25% |
| Sep 30, 2023 | -6.36% |
| Jun 30, 2023 | 6.72% |
| Mar 31, 2023 | 14.73% |
| Dec 31, 2022 | 25.16% |
| Sep 30, 2022 | 17.07% |
| Jun 30, 2022 | 16.84% |
| Mar 31, 2022 | 30.70% |
| Dec 31, 2021 | 32.43% |
| Sep 30, 2021 | 30.18% |
| Jun 30, 2021 | 30.84% |